Guangdong Biolight Meditech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 868.12 million compared to CNY 783.43 million a year ago. Revenue was CNY 868.12 million compared to CNY 783.43 million a year ago.

Net income was CNY 10.21 million compared to CNY 69.4 million a year ago. Basic earnings per share from continuing operations was CNY 0.0396 compared to CNY 0.3167 a year ago. Diluted earnings per share from continuing operations was CNY 0.0396 compared to CNY 0.3167 a year ago.